focus -WSS

focus

author：leisure time 2025-10-01 00:47:17 - browse：21

A radiologist looks at X-rays on screen in a dark room — coverage from STAT — Adobe

Radiology has long led the way in the application of artificial intelligence in medicine. More than three-quarters of AI and machine learning devices authorized by the Food and Drug Administration work with medical images — and that dominance was evident at this year’s meeting of the Radiological Society of North America, where AI vendors gathered to tout their latest offerings.

“How clinical AI is changing radiology for good,” Philips promised to share in a sponsored session. Nuance, the AI-driven voice recognition company acquired by Microsoft last year for $16 billion, sponsored a lunch session on the promise of generative AI to “raise the bar on quality and efficiency,” echoing the frequent claim that AI can solve the plague of physician burnout and staff shortages.

But as pitches for the next generation of AI dominated the demonstration floor, there was tension between excitement and skepticism of the technology. The meeting’s scientific sessions reflected a more mixed reality — one marked with uncertainty and some concern about the real impact of AI tools on patient outcomes.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Study: People of West African ancestry at greater risk of cardiac amyloidosis

focus

WSS

Childhood cancer progress stalls for Black, Hispanic kids: Report

How to improve immunocompromised access to mAb treatments

A daunting task: navigating dual Medicare, Medicaid eligibility

Researchers on aging grapple with how to calculate biological age

Researchers on aging grapple with how to calculate biological age

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

focus

focus

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Use wet bulb globe temperature, not heat index, to protect workers

How to save PrEP access — and even expand it

Medicare says breakthrough device reimbursement rule to come by summer

At least 13 dead in Texas as scorching temps continue

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Moonlake's readout produced a cash windfall. Risks remain

Shionogi licenses Pompe disease therapy from Maze Therapeutics

How one medical school became remarkably diverse

What nurses really want: sufficient staffing for patient care

knowledge

A daunting task: navigating dual Medicare, Medicaid eligibility

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Study: People of West African ancestry at greater risk of cardiac amyloidosis

After gene therapy, two congenitally deaf children hear for the first time

Readout LOUD podcast: brain research, obesity drug sales, Novartis

How to improve immunocompromised access to mAb treatments

knowledge

focus

focus

focus